Switch to:

Denali Therapeutics Non Operating Income

: $0.0 Mil (TTM As of Mar. 2019)
View and export this data going back to 2017. Start your Free Trial

Non-Recurring Items are the incomes received or expenses incurred by the business that are not from regular operations. Denali Therapeutics's non-recurring items for the three months ended in Mar. 2019 was $0.0 Mil. Its non-recurring items for the trailing twelve months (TTM) ended in Mar. 2019 was $0.0 Mil.

As of today, Denali Therapeutics's share price is $20.82. Denali Therapeutics's EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2019 was $-0.59. Therefore, Denali Therapeutics's PE Ratio without NRI ratio for today is .


Denali Therapeutics Non Operating Income Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

Denali Therapeutics Annual Data

Dec15 Dec16 Dec17 Dec18
Non Operating Income 0.00 0.00 0.00 0.00

Denali Therapeutics Quarterly Data

Dec15 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19
Non Operating Income Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Denali Therapeutics Non Operating Income Calculation

Non-Recurring Items are the incomes received or expenses incurred by the business that are not from regular operations. Examples of NRI include gains (losses) from plant shutdown, lease-breaking fees, lawsuit, write-offs, write-downs, restructuring costs or sales of an investment, discontinued operations etc.

NRI can impact a company's reported income drastically.

Non Operating Income for the trailing twelve months (TTM) ended in Mar. 2019 was 0 (Jun. 2018 ) + 0 (Sep. 2018 ) + 0 (Dec. 2018 ) + 0 (Mar. 2019 ) = $0.0 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

GuruFocus lists a PE Ratio without NRI, which is the price/earnings before NRI. We believe it more accurately reflects the valuation of the company.

Denali Therapeutics's PE Ratio without NRI Ratio for today is calculated as

PE Ratio without NRI=Share Price/EPS without NRI
=20.82/-0.59
=

Denali Therapeutics's Share Price of today is $20.82.
Denali Therapeutics's EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2019 was -0.59 (Jun. 2018 ) + -0.38 (Sep. 2018 ) + 0.79 (Dec. 2018 ) + -0.41 (Mar. 2019 ) = $-0.59.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Denali Therapeutics Non Operating Income Explanation


Denali Therapeutics Non Operating Income Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}
FEEDBACK